The Pan African Medical Journal (Jun 2020)

Sclerosing epithelioid fibrosarcoma: rare and serious

  • Mounir Yahyaoui,
  • Mohammed Benhammou,
  • Soufiane Aharram,
  • Jawad Amghar,
  • Mohammed Sadougui,
  • Omar Agoumi,
  • Abdelkrim Daoudi

DOI
https://doi.org/10.11604/pamj.2020.36.131.18668
Journal volume & issue
Vol. 36, no. 131

Abstract

Read online

Sclerosing Epithelioid Fibrosarcoma (SEF) is a rare form of soft tissue sarcoma. It is characterized by a slow evolution, with local recurrences and late metastases that are mainly pulmonary and pleural in about 50% of cases. The treatment is based on the surgery which must be as wide as possible. The efficacy of adjuvant therapy in the control of SEF is not yet demonstrated. Chemotherapy is used in recurrences, some have also proposed radiotherapy. Long-term follow-up of patients with SEF is therefore essential.

Keywords